imatinib mesylate has been researched along with Giant Cell Tumors in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuang, L; Liao, Y; Lv, G; Wang, B; Wang, X | 1 |
| Lewis, VO; Ravi, V; Wang, WL | 1 |
| Blay, JY; Bompas, E; Cassier, PA; Dômont, J; Gelderblom, H; Italiano, A; Kroep, JR; Maki, RG; Seddon, B; Stacchiotti, S; Thomas, D; van der Graaf, WT; Wagner, AJ | 1 |
| Athanasou, NA; Bradley, KM; Dijkstra, PD; Gelderblom, H; Gibbons, CL; Hassan, AB; Hogendoorn, PC; Kroep, JR; Nout, RA; van de Sande, MA; van der Heijden, L; van Rijswijk, CS | 1 |
| Blay, JY; El Sayadi, H; Garret, J; Ray-Coquard, I; Thiesse, P | 1 |
| Buchdunger, E; Dal Cin, P; Dumanski, JP; Heldin, CH; O'Brien, KP; Ostman, A; Pietras, K; Shimizu, A; Sjöblom, T | 1 |
2 review(s) available for imatinib mesylate and Giant Cell Tumors
| Article | Year |
|---|---|
Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.
Topics: Antineoplastic Agents; Benzamides; Giant Cell Tumors; Humans; Imatinib Mesylate; Indoles; Macrophage Colony-Stimulating Factor; Macrophages; Piperazines; Pyrimidines; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Soft Tissue Neoplasms; Sunitinib; Synovial Membrane; Synovitis, Pigmented Villonodular; Tendons | 2011 |
A multidisciplinary approach to giant cell tumors of tendon sheath and synovium--a critical appraisal of literature and treatment proposal.
Topics: Adult; Antineoplastic Agents; Arthroplasty; Arthroscopy; Benzamides; Chemotherapy, Adjuvant; Female; Giant Cell Tumors; Humans; Imatinib Mesylate; Indoles; Interdisciplinary Communication; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Radioisotopes; Radiotherapy, Adjuvant; Sunitinib; Synovectomy; Synovial Membrane; Tendons; Tenosynovitis | 2013 |
4 other study(ies) available for imatinib mesylate and Giant Cell Tumors
| Article | Year |
|---|---|
Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt-related transcription factor 2.
Topics: Apoptosis; Caspase 3; Caspase 9; Cell Proliferation; Cell Survival; Core Binding Factor Alpha 1 Subunit; Gene Expression Regulation, Neoplastic; Giant Cell Tumors; Humans; Imatinib Mesylate; Male; MicroRNAs; Middle Aged; Transfection | 2016 |
Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Piperazines; Pyrimidines; Receptor, Macrophage Colony-Stimulating Factor; Retrospective Studies; Synovitis, Pigmented Villonodular | 2012 |
Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).
Topics: Adult; Antineoplastic Agents; Benzamides; Elbow Joint; Female; Giant Cell Tumors; Humans; Imatinib Mesylate; Joint Diseases; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Synovitis, Pigmented Villonodular; Treatment Outcome | 2008 |
Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
Topics: Adult; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Division; Child, Preschool; Dermatofibrosarcoma; Female; Fibrosarcoma; Giant Cell Tumors; Growth Inhibitors; Humans; Imatinib Mesylate; Infant; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Neovascularization, Pathologic; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Skin Neoplasms; Xenograft Model Antitumor Assays | 2001 |